Skip to main content

TU-F-12A-03: Using 18F-FDG-PET-CT and Deformable Registration During Head-And-Neck Cancer (HNC) Intensity Modulated Radiotherapy (IMRT) to Predict Treatment Response.

Publication ,  Journal Article
Vergalasova, I; Mowery, Y; Yoo, D; Brizel, D; Das, S
Published in: Med Phys
June 2014

PURPOSE: To evaluate the effect of deformable vs. rigid registration of pre-treatment 18F-FDG-PET-CT to intra-treatment 18F-FDG-PET-CT on different standardized uptake value (SUV) parameters and investigate which parameters correlate best with post-treatment response in patients undergoing IMRT for HNC. METHODS: Pre-treatment and intra-treatment PET-CT (after 20Gy) scans were acquired, in addition to a 12 week post-treatment PET-CT to assess treatment response. Primary and lymph node gross tumor volumes (GTV_PRI and GTV_LN) were contoured on the pre-treatment CT. These contours were then mapped to intra-treatment PET images via rigid and deformable registration. Absolute changes from pre- to intra-treatment scans for rigid and deformable registration were extracted for the following parameters: SUV_MAX, SUV_MEAN, SUV_20%, SUV_40%, and SUV_60% (SUV_X% is the minimum SUV to the highest-intensity X% volume). RESULTS: Thirty-eight patients were evaluated, with 27 available for classification as complete or incomplete response (CR/ICR). The pre-treatment average tumor volumes for the patients were 24.05cm(3) for GTV_PRI and 23.4cm(3) for GTV_LN. For GTV_PRI, there was no statistically significant difference between rigid vs. deformable registration across all ΔSUV parameters. For GTV_LN contours, all parameters were significantly different except for ΔSUV_MAX. For deformably-registered GTV_PRI, changes in the following metrics were significantly different for CR vs. ICR: SUV_MEAN(p=0.003), SUV_20%(p=0.02), SUV_40%(p=0.02), and SUV_60%(p=0.008). The following cutoff values separated CR from ICR with high sensitivity and specificity: ΔSUV_MEAN=1.49, ΔSUV_20%=2.39, ΔSUV_40%=1.80 and ΔSUV_60%=1.31. Corresponding areas under the Receiver Operating Characteristics curve were 0.90, 0.81, 0.81, and 0.85, respectively. CONCLUSION: Rigidly and deformably registered contours yielded statistically similar SUV parameters for GTV_PRI, but not GTV_LN. This implies that neither registration should be solely relied upon for nodal GTVs. Of the four SUV parameters found to be predictive of CR vs. ICR, SUV_MEAN was the strongest. Preliminary results show promise for using intra-treatment 18F-FDG-PET-CT with deformable registration to predict treatment response.

Duke Scholars

Published In

Med Phys

DOI

ISSN

0094-2405

Publication Date

June 2014

Volume

41

Issue

6

Start / End Page

480 / 481

Location

United States

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • 5105 Medical and biological physics
  • 4003 Biomedical engineering
  • 1112 Oncology and Carcinogenesis
  • 0903 Biomedical Engineering
  • 0299 Other Physical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vergalasova, I., Mowery, Y., Yoo, D., Brizel, D., & Das, S. (2014). TU-F-12A-03: Using 18F-FDG-PET-CT and Deformable Registration During Head-And-Neck Cancer (HNC) Intensity Modulated Radiotherapy (IMRT) to Predict Treatment Response. Med Phys, 41(6), 480–481. https://doi.org/10.1118/1.4889358
Vergalasova, I., Y. Mowery, D. Yoo, D. Brizel, and S. Das. “TU-F-12A-03: Using 18F-FDG-PET-CT and Deformable Registration During Head-And-Neck Cancer (HNC) Intensity Modulated Radiotherapy (IMRT) to Predict Treatment Response.Med Phys 41, no. 6 (June 2014): 480–81. https://doi.org/10.1118/1.4889358.
Vergalasova, I., et al. “TU-F-12A-03: Using 18F-FDG-PET-CT and Deformable Registration During Head-And-Neck Cancer (HNC) Intensity Modulated Radiotherapy (IMRT) to Predict Treatment Response.Med Phys, vol. 41, no. 6, June 2014, pp. 480–81. Pubmed, doi:10.1118/1.4889358.

Published In

Med Phys

DOI

ISSN

0094-2405

Publication Date

June 2014

Volume

41

Issue

6

Start / End Page

480 / 481

Location

United States

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • 5105 Medical and biological physics
  • 4003 Biomedical engineering
  • 1112 Oncology and Carcinogenesis
  • 0903 Biomedical Engineering
  • 0299 Other Physical Sciences